Medtronic Plc (MDT)

111.18
NYSE : Health Technology
Prev Close 111.01
Day Low/High 110.65 / 111.60
52 Wk Low/High 81.66 / 111.73
Avg Volume 4.46M
Exchange NYSE
Shares Outstanding 1.34B
Market Cap 148.94B
EPS 3.40
P/E Ratio 33.23
Div & Yield 2.16 (1.85%)

Latest News

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

Real Money Post-Industrial Average Leads Major Indexes So Far for Year

In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.

Dexcom Looks Like It Can Finally Break Out on the Topside

Dexcom Looks Like It Can Finally Break Out on the Topside

Let's check the charts and indicators on the glucose-monitoring company.

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Real Money Post-Industrial Index Continues to Outperform Major Market Indices

Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.

Medtronic Is Edging Closer to an Upside Breakout on the Charts

Medtronic Is Edging Closer to an Upside Breakout on the Charts

No one knows their business as well as the CEO.

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

Trade War Heats Up, Fundamental Analysis, Boeing on the Hot Seat: Market Recon

China's President Xi has obviously found surrender distasteful.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

A Technical Strategy for Tandem Diabetes Care

A Technical Strategy for Tandem Diabetes Care

Are we late to the game with the stock up so much?

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

Real Money Post-Industrial Average Shines in January, Outperforming S&P 500

RMPIA soared 9.9% for the month, led by 11 double-digit gainers.

Medtronic Stock Is Showing Promise on the Daily Chart

Medtronic Stock Is Showing Promise on the Daily Chart

Here's how to trade MDT, going long.

Medtronic Upgraded to Buy at BTIG Research

8 Top Year-End Trading Ideas for Bargain Hunters

8 Top Year-End Trading Ideas for Bargain Hunters

These eight S&P 500 stocks have some of the worst returns year-to-date and represent a diverse roster of promising bounce candidates.

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Medtronic Is Testing the 200-Day Average and I Am Not Too Optimistic

Prices are testing the October and November lows and also testing the rising 200-day moving average line.

Rattled? The Only Obstacle Is the One in Front of You: Market Recon

Rattled? The Only Obstacle Is the One in Front of You: Market Recon

Everyone gets knocked down. What is different about you is that you are as tough as these markets.

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Real Money Post-Industrial Average Beat Nasdaq Comp in November's First Half

Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

Jim Cramer: Know Which Way the Wind Blows Before You Pick Stocks

PepsiCo, GE and just like the weather, the stock market is subject to change.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

3 Ways to Play Lululemon on This Rise: Market Recon

3 Ways to Play Lululemon on This Rise: Market Recon

LULU is up 70% since March. This is how to get into the name in an intelligent way.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Jim Cramer: Tech Can't Do it All Alone

Jim Cramer: Tech Can't Do it All Alone

Tech and retail gains aren't enough to lead markets to new highs.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

Medtronic's Rally Doesn't Look All That Healthy

Medtronic's Rally Doesn't Look All That Healthy

Charts say the medical-devices firm should have a price target 16% above current levels, but one indicator fails to confirm that.

Jim Cramer: We Have Some Strong Opportunities to Make Some Money Here

Jim Cramer: We Have Some Strong Opportunities to Make Some Money Here

All of these stocks are standard go-to names when inflation is peaking.

Easing Dodd-Frank Regulations on Smaller Banks Was Long Overdue: How to Play It

Easing Dodd-Frank Regulations on Smaller Banks Was Long Overdue: How to Play It

Relief is on the way, and there's an inexpensive beneficiary out in California.

These Stocks Are Showing Reversal Patterns

These Stocks Are Showing Reversal Patterns

A look at stocks seeing bullish and bearish reversal characteristics over the past week.

Closing Bell: Stocks Finish Tuesday Strong as Tech, Healthcare Take the Lead

Closing Bell: Stocks Finish Tuesday Strong as Tech, Healthcare Take the Lead

After two weeks of losses, the three benchmark indexes come out swinging on Tuesday. Tech and healthcare strength bolstered Wall Street gains.